VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 87 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $1,052,000 | +24.2% | 113,165 | +38.7% | 0.04% | +33.3% |
Q3 2014 | $847,000 | -59.7% | 81,600 | -37.2% | 0.03% | -63.3% |
Q2 2014 | $2,103,000 | +15.8% | 130,000 | -11.2% | 0.09% | -22.4% |
Q4 2013 | $1,816,000 | +295.6% | 146,350 | +157.5% | 0.12% | +274.2% |
Q2 2013 | $459,000 | – | 56,843 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |